SCHEMBL20635554

SCHEMBL20635554

Cc1c(OC(=O)CCC(P(=O)(O)O)P(=O)(O)O)cc2c(c1C)OC(C)(CCCC(C)CCCC(C)CCCC(C)C)CC2

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 7/20 0.60
GSTO1 P78417 2/20 0.58
PTPN1 P18031 1/20 0.58
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
PDE4A P27815 1/20 0.55
PDE3A Q14432 1/20 0.55
PDPK1 O15530 2/20 0.55
PHLPP1 O60346 2/20 0.55
ILK Q13418 2/20 0.55
LMNA P02545 3/20 0.54
PSEN1 P49768 2/20 0.51
ALOX5 P09917 1/20 0.50
NR1I2 O75469 1/20 0.50
MAPT P10636 2/20 0.48
GSTP1 P09211 1/20 0.48
TTPA P49638 1/20 0.48
USP2 O75604 1/20 0.48
THRB P10828 1/20 0.48
CYP2C9 P11712 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20635558 0.90 AKT1 (0.57) AKT1GSTO1PTPN1MEN1KMT2A
SCHEMBL708743 0.88 GSTO1 (0.74) AKT1GSTO1PTPN1MEN1KMT2A
SCHEMBL20635626 0.87 LMNA (0.60) AKT1GSTO1PTPN1MEN1KMT2A
SCHEMBL20635617 0.86 GSTO1 (0.77) AKT1GSTO1PTPN1MEN1KMT2A
SCHEMBL708419 0.86 MEN1 (0.71) AKT1GSTO1PTPN1MEN1KMT2A
SCHEMBL29390266 0.86 MEN1 (0.71) AKT1GSTO1PTPN1MEN1KMT2A
SCHEMBL8894988 0.85 GSTO1 (0.71) AKT1GSTO1PTPN1MEN1KMT2A
SCHEMBL14359795 0.85 AKT1 (0.60) AKT1GSTO1PTPN1MEN1KMT2A
SCHEMBL29959827 0.84 AKT1 (0.64) AKT1GSTO1PTPN1MEN1KMT2A
SCHEMBL20634804 0.82 GSTO1 (0.57) AKT1GSTO1PTPN1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230027148-A1 MULTIFUNCTIONAL CONJUGATES E.P.O.S IASIS RESEARCH AND DEVELOPMENT LIMITED (CY) 2023-01-26 US disclosed
US-11400160-B2 Multifunctional conjugates E.P.O.S IASIS RESEARCH AND DEVELOPMENT LIMITED (CY) 2022-08-02 US disclosed
US-20200164076-A1 MULTIFUNCTIONAL CONJUGATES E.P.O.S IASIS RESEARCH AND DEVELOPMENT LIMITED (CY) 2020-05-28 US disclosed
WO-2019007447-A1 MULTIFUNCTIONAL CONJUGATES E.P.O.S IASIS RESEARCH AND DEVELOPMENT LIMITED (CY) 2019-01-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230027148-A1 MULTIFUNCTIONAL CONJUGATES MKI67, ACP3, CD44 AKT1 714/4885GSTO1 148/4885PTPN1 1238/4885
US-20200164076-A1 MULTIFUNCTIONAL CONJUGATES MKI67, ACP3, CD44 AKT1 779/4885GSTO1 164/4885PTPN1 1198/4885
US-11400160-B2 Multifunctional conjugates MKI67, ACP3, CD44 AKT1 779/4885GSTO1 164/4885PTPN1 1198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.